Traws Pharma, Inc. (TRAW)
NASDAQ·Healthcare·Biotechnology
$1.20
+5.26%
Mkt Cap $7.96M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q2 2026 Apr 15, 2026 | $60.00K | $57.00K | -5.00% | -$1.22 | -$0.82 | +33.00% | — | — |
| Q4 2025 Nov 13, 2025 | $60.00K | $2.73M | +4455.00% | -$9.16 | -$0.34 | +96.29% | — | — |
| Q3 2025 Aug 14, 2025 | $60.00K | $2.73M | +4455.00% | -$8.75 | -$0.11 | +98.74% | — | — |
| Q2 2025 May 15, 2025 | $60.00K | $57.00K | -5.00% | -$8.04 | $2.09 | +126.00% | — | — |
| Q1 2025 Mar 31, 2025 | $60.00K | $56.00K | -6.67% | -$9.55 | $95.66 | +1101.68% | — | — |
| Q4 2024 Nov 14, 2024 | $60.00K | $56.00K | -6.67% | -$6.25 | -$8.81 | -40.96% | — | — |
| Q3 2024 Aug 15, 2024 | $60.00K | $57.00K | -5.00% | -$6.25 | -$121.75 | -1848.00% | — | — |
| Q2 2024 May 15, 2024 | $60.00K | $113.00K | +88.33% | -$6.00 | -$6.00 | +0.00% | — | — |
| Q2 2024 Apr 1, 2024 | $65.33K | $56.00K | -14.29% | -$0.25 | -$0.19 | +24.00% | — | — |
| Q4 2023 Nov 14, 2023 | $69.25K | $113.00K | +63.18% | -$0.26 | -$0.23 | +11.54% | — | — |
| Q3 2023 Aug 10, 2023 | $69.25K | $57.00K | -17.69% | -$7.81 | -$5.00 | +36.00% | — | — |
| Q1 2023 Mar 16, 2023 | $80.00K | $46.00K | -42.50% | -$6.94 | -$6.50 | +6.31% | — | — |
| Q4 2022 Dec 31, 2022 | $79.00K | $113.00K | +43.04% | -$7.44 | -$12.92 | -73.77% | — | — |
| Q3 2022 Aug 11, 2022 | $73.00K | $57.00K | -21.92% | -$0.20 | -$0.19 | +3.80% | — | — |
| Q2 2022 Jun 30, 2022 | $73.67K | $113.00K | +53.39% | -$5.31 | -$9.74 | -83.38% | — | — |
| Q4 2021 Dec 31, 2021 | $79.00K | $113.00K | +43.04% | -$0.19 | -$8.63 | -4505.13% | — | — |
| Q2 2021 Jun 30, 2021 | — | $113.00K | — | — | -$14.17 | — | — | — |
| Q4 2020 Dec 31, 2020 | — | $123.00K | — | — | -$25.55 | — | — | — |
| Q2 2020 Jun 30, 2020 | — | $108.00K | — | — | -$27.62 | — | — | — |
| Q4 2019 Dec 31, 2019 | — | $93.00K | — | — | -$34.89 | — | — | — |